NovoSeven RT Australia - engelsk - Department of Health (Therapeutic Goods Administration)

novoseven rt

novo nordisk pharmaceuticals pty ltd - eptacog alfa (activated); histidine -

GLUCAGEN HYPOKIT 1mg powder for injection vial with diluent syringe Australia - engelsk - Department of Health (Therapeutic Goods Administration)

glucagen hypokit 1mg powder for injection vial with diluent syringe

novo nordisk pharmaceuticals pty ltd - glucagon, quantity: 1 mg (equivalent: glucagon, qty 1 iu) - diluent, not applicable - excipient ingredients: water for injections - therapeutic: treatment of severe hypoglycaemic reactions which may occur in the management of diabetic patients receiving insulin or oral hypoglycaemic agents. to prevent the occurrence of secondary hypoglycaemia, oral carbohydrate should be given to restore the hepatic glycogen when the patient has responded to the treatment. the mechanism and hence treatment of sulfonylurea-induced hypoglycaemia differs from that of severe insulin-induced hypoglycaemia in some important ways. consciousness should preferably be restored by the administration of intravenous glucose. if glucagon is used due to the unavailability of intravenous glucose (e.g. before reaching a hospital) care should be taken to protect against secondary hypoglycaemia with constant monitoring of the patient's blood sugar level by medical personnel. subsequent administration of intravenous glucose may be required.,diagnostic: motility inhibitor in examinations of the gastrointestinal tract in adults, e.g. double contrast radiography and endoscop

KLIOVANCE estradiol 1mg and norethisterone acetate 0.5mg tab dialdispenserpack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

kliovance estradiol 1mg and norethisterone acetate 0.5mg tab dialdispenserpack

novo nordisk pharmaceuticals pty ltd - estradiol hemihydrate, quantity: 1.03 mg (equivalent: estradiol, qty 1 mg); norethisterone acetate, quantity: 0.5 mg - tablet, film coated - excipient ingredients: maize starch; copovidone; lactose monohydrate; purified talc; hypromellose; triacetin; magnesium stearate - short term treatment of menopausal symptoms related to oestrogen deficiency in women more than one year after menopause (see dosage and administration and clinical trials). for the prevention of postmenopausal bone mineral density loss. when prescribed solely for the prevention of postmenopausal bone mineral density loss, therapy should only be prescribed for women who are at high risk of osteoporosis and future fracture and who are intolerant of, or contraindicated for, non-oestrogen products approved for prevention of osteoporosis. life style modifications and the risk benefit profiles of kliovance should be taken into careful consideration and discussed with the patient, to allow the patient to make an informed decision prior to prescribing. see precautions and dosage and administration.

TRISEQUENS estradiol tablets and norethisterone acetate plus estradiol  tablets dial dispenser pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

trisequens estradiol tablets and norethisterone acetate plus estradiol tablets dial dispenser pack

novo nordisk pharmaceuticals pty ltd - estradiol hemihydrate, quantity: 2.07 mg (equivalent: estradiol, qty 2 mg); norethisterone acetate, quantity: 1 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; hyprolose; purified talc; magnesium stearate; hypromellose; triacetin - short term symptomatic treatment of oestrogen deficiency associated with natural or artificial menopause (see dosage and administration and clinical trials).

ESTROFEM estradiol (as hemihydrate) 2mg tablet dial dispenser pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

estrofem estradiol (as hemihydrate) 2mg tablet dial dispenser pack

novo nordisk pharmaceuticals pty ltd - estradiol hemihydrate, quantity: 2.07 mg (equivalent: estradiol, qty 2 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; purified talc; magnesium stearate; titanium dioxide; hypromellose; hyprolose; indigo carmine; macrogol 400 - short term symptomatic treatment of oestrogen deficiency due to natural or surgical menopause in hysterectomised postmenopausal women. in women with intact uteri, use of opposed therapy must be considered.

ESTROFEM estradiol (as hemihydrate) 1mg tablet dial dispenser pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

estrofem estradiol (as hemihydrate) 1mg tablet dial dispenser pack

novo nordisk pharmaceuticals pty ltd - estradiol hemihydrate, quantity: 1.03 mg (equivalent: estradiol, qty 1 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; purified talc; magnesium stearate; titanium dioxide; hypromellose; hyprolose; iron oxide red; propylene glycol - short term symptomatic treatment of oestrogen deficiency due to natural or surgical menopause in hysterectomised postmenopausal women. in women with intact uteri, use of opposed therapy must be considered.

PROTAPHANE PENFILL human insulin (rys) 100IU/mL injection multidose cartridge Australia - engelsk - Department of Health (Therapeutic Goods Administration)

protaphane penfill human insulin (rys) 100iu/ml injection multidose cartridge

novo nordisk pharmaceuticals pty ltd - insulin, quantity: 100 iu/ml - injection, suspension - excipient ingredients: dibasic sodium phosphate dihydrate; phenol; hydrochloric acid; water for injections; metacresol; zinc chloride; protamine sulfate; sodium hydroxide; glycerol - the treatment of insulin-requiring diabetes.

PROTAPHANE INNOLET human insulin (rys) 100IU/mL injection multidose cartridge Australia - engelsk - Department of Health (Therapeutic Goods Administration)

protaphane innolet human insulin (rys) 100iu/ml injection multidose cartridge

novo nordisk pharmaceuticals pty ltd - insulin, quantity: 100 iu/ml - injection, suspension - excipient ingredients: hydrochloric acid; zinc chloride; protamine sulfate; sodium hydroxide; metacresol; dibasic sodium phosphate dihydrate; water for injections; glycerol; phenol - the treatment of insulin-requiring diabetes.

MIXTARD 50/50 PENFILL human insulin (rys) 100IU/mL injection multidose cartridge Australia - engelsk - Department of Health (Therapeutic Goods Administration)

mixtard 50/50 penfill human insulin (rys) 100iu/ml injection multidose cartridge

novo nordisk pharmaceuticals pty ltd - insulin, quantity: 50 iu/ml - injection, suspension - excipient ingredients: dibasic sodium phosphate dihydrate; glycerol; metacresol; hydrochloric acid; zinc chloride; sodium hydroxide; phenol; water for injections; protamine sulfate - the treatment of insulin-requiring diabetes.